Huntington'S Disease

Overview

Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by CAG trinucleotide repeat expansion in the HTT gene, producing mutant huntingtin protein (mHTT) with an extended polyglutamine tract. While the genetic cause is well-established, the mechanisms of selective neuronal death in the striatum and cortex remain incompletely understood. Emerging evidence suggests that metal accumulation and brain-associated microbial communities may modify disease progression independently of the primary genetic lesion.

Microbiome Associations

Brain Microbiota

Post-mortem examination of HD brain tissue has revealed fungal elements including Candida species in multiple brain regions, paralleling findings by the same research group (Carrasco laboratory) in alzheimers disease, parkinsons disease, and ALS alonso 2021 brain microbiota huntingtons. Whether these represent true colonization, blood-brain barrier breach during disease, or post-mortem contamination remains debated — but the consistency of findings across neurodegenerative diseases and across multiple independent studies suggests biological significance.

Gut Microbiome

HD patients and presymptomatic gene carriers show altered gut microbiome composition compared to healthy controls. intestinimonas has been reported as enriched in HD, consistent with its enrichment in other inflammatory and neurodegenerative states. Gut-brain axis disruption in HD may contribute to the gastrointestinal symptoms (weight loss, dysphagia, altered motility) that precede or accompany motor decline.

Metal Associations

Metal accumulation in the HD brain is increasingly documented:

  • Iron — Elevated in the caudate nucleus and putamen (the regions most affected in HD). Iron accumulation accelerates oxidative damage via Fenton chemistry and promotes alpha synuclein-independent protein aggregation. Neuroimaging studies show iron deposition correlating with disease severity and motor dysfunction.
  • Manganese — Accumulates in the basal ganglia; manganese neurotoxicity preferentially affects the same striatal circuits destroyed in HD, raising the possibility that environmental manganese exposure modifies age of onset or progression rate.
  • Copper — Mutant huntingtin interacts abnormally with copper, and copper dyshomeostasis has been reported in HD models. Copper-mediated oxidative stress may compound iron-driven damage.

The convergence of metal accumulation in the same brain regions where mHTT causes selective neuronal death suggests that metals may not merely accompany neurodegeneration but actively accelerate it — particularly in individuals with subthreshold genetic risk (intermediate CAG repeats).

Associated Conditions

HD shares neuropathological and metallomic features with other neurodegenerative diseases:

  • parkinsons disease — Shared iron and manganese accumulation in basal ganglia; overlapping brain fungal findings; both show gut-brain axis disruption
  • alzheimers disease — Shared iron and copper dysregulation; overlapping Candida detection in brain tissue; protein aggregation mechanisms

Environmental Factors

Dietary and occupational manganese exposure may modify HD progression. Manganese-contaminated groundwater, soy-based infant formula (high Mn content), and occupational exposure in welding or mining are potential environmental modifiers for genetically susceptible individuals.

Open Questions

  • Do brain-associated fungi in HD represent active infection, dormant colonization, or translocation through a compromised BBB?
  • Does iron chelation therapy (deferiprone) slow HD progression, as has been explored in PD?
  • Is the gut microbiome a modifiable risk factor for age of onset in HD gene carriers?
  • Does manganese exposure interact with CAG repeat length to determine disease severity?

Cross-References

Related Articles